Anavex Life Sciences Corp (AVXL)

[Investor2014]

Not to forget that we are still waiting after two years on the expected PDD peer reviewed paper.

as in the listed Catalysts for 2H of 2022

I suppose that provides a yard stick for how long we might have to wait for the P2b/3 peer reviewed publication to finally give us the full detail of how the trial met all endpoints.

Oh the suspense! maybe on the way some of the tension will be released by the grand revelation of the secrete rare disase indication.

No lying going on at all, just a bit of tardiness.